It is an honor to recognize Adam J. Gordon, MD, MPH, FACP, DFASAM, on his appointment as holder of the Jon M. Huntsman Presidential Chair in the Department of Internal Medicine at the University of Utah, effective July 1, 2025.
Dr. Gordon was formally appointed by Taylor Randall, President of the University of Utah, to a three-year term ending June 30, 2028. This prestigious chair recognizes sustained excellence in scholarship, leadership, and impact across research, education, and clinical care.
Dr. Gordon is a nationally and internationally recognized leader in addiction medicine and the care of vulnerable populations. Over his 22-year career, he has secured more than $100 million in research funding from agencies including the NIH, VA, AHRQ, PCORI, and SAMHSA. He is the founder and director of the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), which has grown into a thriving interdisciplinary initiative with more than 35 affiliated faculty advancing addiction science and health equity.
He also serves as Principal Investigator of the Greater Intermountain Node of the NIH’s National Institute on Drug Abuse Clinical Trials Network, bringing cutting-edge addiction research to the region. His leadership of major VA initiatives focused on opioid use disorder treatment has helped educate and mentor tens of thousands of clinicians nationwide.
A prolific scholar with an H-index of 62 and more than 369 peer-reviewed publications, Dr. Gordon has maintained continuous independent funding since 2000. He is equally distinguished as a mentor, having guided numerous trainees and junior faculty to successful VA and NIH career development awards and earning national recognition for excellence in mentorship.
We congratulate Dr. Gordon on this well-deserved honor and look forward to the continued impact of his visionary leadership in addiction medicine, research, and advocacy at the University of Utah and beyond.